Creutzfeldt-Jakob Disease Foundation Inc logo

The Dr. Robert Brooks Memorial Grant

Creutzfeldt-Jakob Disease Foundation Inc

Foundation Annual Grants for Science Research

Funding Amount

Varies

Deadline

Deadline not published

Grant Type

Foundation

Deadline history & next window

Cycle
Annual
Tracked since
April 2026

Source: the cycle recorded on this listing. Confirm dates with the funder.

Overview

Established: 2022

Contributed by: Loving Family & Friends

Focus Area: Prion disease research with emphasis on therapeutic compounds

Geographic Scope: United States (supported research in Ohio)

Mission: Supports research into treatment approaches for CJD

Contact Information

  • Toll-Free Helpline: 1-800-659-1991
  • Email: help@cjdfoundation.org
  • Address: 3634 W. Market Street, Suite 110, Akron, OH 44333
  • Website: cjdfoundation.org

Recent Grant Awards

  • Zerui Wang, MD, PhD and Katsumi Doh-ura, MD, PhD (2022) - "Assessing Prophylactic and Therapeutic Efficacy of a Cellulose Ether Compound TC-5RW on CJD" (Department of Pathology, Case Western Reserve University, Cleveland, Ohio)

What Creutzfeldt-Jakob Disease Foundation Inc actually gave

Source: IRS Form 990, 2024

Grants in 2024
2
Total given
$200K
Median grant
$100K
  • By dollars: Ohio 50%, Maryland 50%. Top recipient cities: Cleveland, OH; Bethesda, MD.

Example grants

  • Case Western Reserve · Cleveland, OH

    Research

    $100K

  • National Institute of Allergy and Infectious Diseases · Bethesda, MD

    Research

    $100K

IRS Form 990, 2024. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for The Dr. Robert Brooks Memorial Grant?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found The Dr. Robert Brooks Memorial Grant. Now let's win it.

Start writing